Home › FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...
 

Keywords :   


FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...

2013-09-28 10:29:05| Biotech - Topix.net

International drug manufacturer Actavis, Inc. has agreed to sell all rights and assets to four generic pharmaceuticals - three oral contraceptives and an osteoporosis treatment - to settle FTC charges that its proposed $8.5 billion acquisition of drug-maker Warner Chilcott plc would be anticompetitive.

Tags: proposed charges billion acquisition

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.11 EVA 6
23.11 8
23.11SEVENTEEN ALWAYS YOURS Weverse 13
23.11 DX
23.11 No.23/1998
23.11 DVD 9
23.11
23.11 CD His Melody
More »